APA (7th ed.) Citation

K, I., Y, N., K, K., M, F., N, G., H, T., . . . K, U. (2026). Usefulness of an S-1 dosage formula for predicting adverse events in adjuvant chemotherapy for curatively resected pancreatic cancer: An exploratory analysis of the randomized clinical trial (JASPAC-01). Journal of gastroenterology, 61(6), 821. https://doi.org/10.1007/s00535-026-02413-5

Chicago Style (17th ed.) Citation

K, Ishigaki, et al. "Usefulness of an S-1 Dosage Formula for Predicting Adverse Events in Adjuvant Chemotherapy for Curatively Resected Pancreatic Cancer: An Exploratory Analysis of the Randomized Clinical Trial (JASPAC-01)." Journal of Gastroenterology 61, no. 6 (2026): 821. https://doi.org/10.1007/s00535-026-02413-5.

MLA (9th ed.) Citation

K, Ishigaki, et al. "Usefulness of an S-1 Dosage Formula for Predicting Adverse Events in Adjuvant Chemotherapy for Curatively Resected Pancreatic Cancer: An Exploratory Analysis of the Randomized Clinical Trial (JASPAC-01)." Journal of Gastroenterology, vol. 61, no. 6, 2026, p. 821, https://doi.org/10.1007/s00535-026-02413-5.